Advances in clinical research methodology for pain clinical trials.
Pain is a ubiquitous phenomenon, but the experience of pain varies considerably from person to person. Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.
Farrar
John T
JT
University of Pennsylvania, Philadelphia, Pennsylvania, USA. jfarrar@upenn.edu
D000818:Animals; D035843:Biomedical Research / Q000379:methods* / Q000639:trends*; D016022:Case-Control Studies; D002986:Clinical Trials as Topic / Q000379:methods* / Q000639:trends*; D006801:Humans; D010146:Pain / Q000473:pathology* / Q000503:physiopathology; D010147:Pain Measurement